Research advance of early biomarkers on acute kidney injury in sepsis

VernacularTitle:脓毒症并发急性肾损伤的早期生物标记物的研究进展
Author: Jianru XU ; Siyuwei CAO ; Ming JIANG
Keywords: acute kidney injury; sepsis; biomarker; calprotectin; interleukin-18
From: Chinese Journal of Biochemical Pharmaceutics 2017;37(3):27-29
CountryChina
Language:Chinese
Abstract: Sepsis, the most common panthogeny, is characterized as multi-system injuries like immune system, inflammatory system and coagulation system, caused by systemic inflammatory response syndrome ( SIRS) and excessive oxidative stress after the invasion of pathogen.Severe cases can lead to multiple organ dysfunction syndrome and even death.Acute kidney injury is an independent risk factor which has an influence on patients'prognosis.Currently, the research of biomarkers of AKI is a significant field.Some new biomarkers are found to be charaterised by early appearance in blood or urine, non-traumatic and sensitivity in recent years, which contribute to their applications in early diagnosis of AKI.At present, the biomarkers of early diagnosis of AKI, such as calprotectin, interleukin-18, neutrophil gelatinase associated lipocalin (NGAL), cysteine protease inhibitor C, kidney injury molecule-1 (KIM-1) and cysteine rich 61, are under study.The current basic research and a few clinical studies show that these indicators may have a better sensitivity .